earnings
TP
NASDAQ · TPST
Tempest Therapeutics, Inc.
Healthcare · Biotechnology
$0.78
Down-$0.04 (-4.96%)
Updated Sep 15, 2026, 3:35 PM
SID Score
2.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 14.1M
- P/E ratio
- -0.28
- Dividend yield
- 0.00%
- 52-week range
- $0.75 – $6.12
- Volume
- 143.42K
- Avg. volume
- 107.23K
Price performance
TPST price history
1M range · 20 trading sessions · Daily adjusted prices
TPST closed at $0.78 after 20 trading sessions, down 30.59% for the selected period.
- Last close
- $0.78
- Period change
- -30.59%
- Period low
- $0.78
- Period high
- $1.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.80 | $0.8221 | $0.7522 | $0.7843 | 143.42K |
| Sep 11, 2026 | $0.79 | $0.8872 | $0.7583 | $0.8117 | 783.63K |
| Sep 10, 2026 | $0.95 | $0.95 | $0.80 | $0.8026 | 391.01K |
| Sep 9, 2026 | $0.985 | $0.99 | $0.9088 | $0.9089 | 189.5K |
| Sep 8, 2026 | $1.02 | $1.03 | $0.976 | $0.9872 | 199.94K |
| Sep 4, 2026 | $1.04 | $1.05 | $1.01 | $1.03 | 214.71K |
| Sep 3, 2026 | $1.10 | $1.10 | $1.04 | $1.05 | 182.26K |
| Sep 2, 2026 | $1.05 | $1.12 | $1.05 | $1.10 | 127.7K |
| Sep 1, 2026 | $1.07 | $1.08 | $1.0311 | $1.05 | 177.33K |
| Aug 31, 2026 | $1.06 | $1.13 | $1.06 | $1.09 | 60.83K |
| Aug 28, 2026 | $1.0919 | $1.10 | $1.04 | $1.06 | 64.07K |
| Aug 27, 2026 | $1.10 | $1.11 | $1.0749 | $1.08 | 70.5K |
| Aug 26, 2026 | $1.1088 | $1.1095 | $1.07 | $1.08 | 51.77K |
| Aug 25, 2026 | $1.11 | $1.13 | $1.08 | $1.11 | 75.81K |
| Aug 24, 2026 | $1.05 | $1.14 | $1.01 | $1.10 | 201.24K |
| Aug 21, 2026 | $1.02 | $1.08 | $1.00 | $1.04 | 133.86K |
| Aug 20, 2026 | $1.05 | $1.0748 | $1.005 | $1.02 | 89.58K |
| Aug 19, 2026 | $1.02 | $1.08 | $1.02 | $1.07 | 155.96K |
| Aug 18, 2026 | $1.11 | $1.11 | $1.0101 | $1.07 | 334.95K |
| Aug 17, 2026 | $1.09 | $1.17 | $1.045 | $1.13 | 818.48K |
Latest TPST news
The latest Smart Investors Daily articles mentioning TPST.
Stock researchCompany · Financials
Loading stock research…

